This short video shows a flyer that the Northern Sierra Coalition used to get information out about pain medications and naloxone.

Dr. Willis discusses what strategies to use to lower the opioid supply and to safely manage chronic pain. He also addresses the steps of recovery for those who are experiencing opioid use disorder.

Dr. Grover discusses how doctors can reduce the opioid supply and use safer prescribing methods for chronic pain.

This video discusses strategies to effectively reduce the opioid supply.

The Overdose Prevention Initiative (OPI) team has created a Fentanyl Test Strips (FTS) Frequently Asked Questions (FAQ’s). This resource is located on the Substance and Addiction Prevention Branch page listed under: Publications and on the fentanyl resource page listed under: Why is fentanyl dangerous.

From the start, patients like Richard (Ricky) Dominguez gravitated toward the telehealth counseling service, which they found much more accessible than in-person services. Dominguez, 26, has been battling substance use disorder since he was twelve. At the emergency room at a local hospital, he was referred to KCS, which, he says, “was a godsend.”

This fact sheet covers the main discussion points and answered questions from the COPN webinar “Naloxone Supply in California.”

This fact sheet answers frequently asked questions about fentanyl, buprenorphine, and the impact fentanyl has on overdose prevention efforts.

Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. Harm Reduction is also a movement for social justice built on a belief in, and respect for, the rights of people who use drugs.

Harm reduction strategies and tools should be accessible to everyone – regardless of location, time and or experience. National Harm Reduction Coalition offers a series of self-paced online learning modules that groups and individuals can complete on their own schedule and terms – anytime, anywhere.

The National Harm Reduction Coalition (NHRC) offers evidence-based strategies that reduce the risk of dying from an overdose. It aims to support people who use drugs, and the people who love people who use drugs, with information to mitigate the risk of an overdose and to stop an overdose while it’s happening.

Most overdose deaths are preventable, but the "tough on crime" rhetoric of the decades-long drug war and the stigma associated with drug use have blocked the widespread adoption of life-saving overdose prevention and treatment policies. The Drug Policy Alliance (DPA) is leading the national effort to reduce drug overdose deaths by promoting sensible, evidence-based solutions at the state and federal level.

This video offers a new perspective on the effects of fentanyl on the brain, and how fentanyl has changed the landscape of overdose prevention.

Learn about New York's Project COPE, which focuses on harm reduction and how you can help prevent overdoses in your community.

Many individuals consume fentanyl without their knowledge (because they do not realize that it is in a product they’re using), while others are intentionally using fentanyl because of its potency. It is partly responsible for the current overdose crisis in the U.S., combined with a lack of resources and the criminalization of people who use drugs. This fact sheet from the National Harm Reduction Coalition (NHRC) addresses some of the myths and lesser known facts about fentanyl.

This video explains the importance of primary care in treating substance use disorder, and how providers can work to decrease the stigma around treatment services.

Use this toolkit from the California Department of Public Health (CDPH) to share information about the risks of fentanyl and how to prevent overdose.

Access to naloxone isn’t just a funding issue. Barriers to accessing low-cost naloxone are a result of the decades-long war on drugs. This organization is working to eliminate barriers from three different angles: distribution, technical assistance, and research.

The Chicago Recovery Alliance (CRA) is a racially and ethnically diverse group composed of people living with HIV and drug use, working in addiction treatment, healthcare, education, law and other assorted areas. CRA is unique as an organization in that our work entails building one-on-one relationships with individuals affected by HIV and drug use and provide them with a wide array of options for achieving any positive change as they define it for themselves. CRA is an organization for those interested in directly serving, supporting, educating and advocating with others for reducing drug related harm.

This fact sheet makes the case for contingency management as a behavioral treatment option to addressing SUD. It explains some of the legal barriers to implementing contingency management on a wide scale, and why it is important to embrace methods other than medicine in our efforts.